The PET tracer [ 11 C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PET tracer [
11
C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 627, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-01-13
DOI
10.1126/scitranslmed.abg3684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases
- (2020) Ling Tong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
- (2019) Christine Bastin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
- (2019) Sean P. Moran et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M 4 PAM VU0467154
- (2018) Robert W. Gould et al. NEUROPHARMACOLOGY
- Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases
- (2018) Christian C. Felder et al. NEUROPHARMACOLOGY
- Allosteric modulators targeting CNS muscarinic receptors
- (2018) Andreas Bock et al. NEUROPHARMACOLOGY
- Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease
- (2018) E.P. Lebois et al. NEUROPHARMACOLOGY
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
- (2018) Ming-Kai Chen et al. JAMA Neurology
- Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline
- (2018) Catherine A. Thorn et al. ACS Chemical Neuroscience
- The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia
- (2018) Anu G. Nair et al. NEUROPHARMACOLOGY
- Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
- (2017) Daniel J. Foster et al. NEURON
- Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer’s disease
- (2016) Elizabeth Scarr et al. JOURNAL OF NEURAL TRANSMISSION
- Regional covariance of muscarinic acetylcholine receptors in Alzheimer’s disease using (R, R) [123I]-QNB SPECT
- (2015) Sean J. Colloby et al. JOURNAL OF NEUROLOGY
- M4 mAChR-Mediated Modulation of Glutamatergic Transmission at Corticostriatal Synapses
- (2014) Tristano Pancani et al. ACS Chemical Neuroscience
- Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
- (2014) Michael Bubser et al. ACS Chemical Neuroscience
- Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey
- (2014) Joshua D. Vardigan et al. PSYCHOPHARMACOLOGY
- Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
- (2013) M.-Marsel Mesulam JOURNAL OF COMPARATIVE NEUROLOGY
- Translational PET imaging research
- (2013) Richard J. Hargreaves et al. NEUROBIOLOGY OF DISEASE
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Cholinergic modulation of response gain in the primary visual cortex of the macaque
- (2011) Shogo Soma et al. JOURNAL OF NEUROPHYSIOLOGY
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography
- (2010) Tsuneyoshi Ota et al. CLINICAL NEUROPHARMACOLOGY
- Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
- (2010) Deranda B Lester et al. CNS Neuroscience & Therapeutics
- Histamine H3 inverse agonist PET tracers labelled with carbon-11 or fluorine-18
- (2008) Terence G. Hamill et al. NEUROIMAGE
- Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
- (2008) W. Y. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
- (2007) Martin Steinberg et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started